Moderna Prices $2.6 Billion Convertible Notes due 2032

MT newswire2026/08/28 11:23

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

07:23 AM EDT, 08/28/2026 (MT Newswires) -- Moderna (MRNA) priced a $2.6 billion offering of convertible senior notes due 2032, up from the previously announced $2 billion, the company said Friday. Initial purchasers were granted an option to buy up to an additional $400 million of notes, the company said. The company expects to use the net proceeds to pay the cost of certain capped call transactions and for general corporate purposes, including potential investments in its oncology business and debt repayment, it added. The company expects the sale to initial purchasers to close Tuesday.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03